Home › Funds › DIADEMA PARTNERS LP › CAPR
DIADEMA PARTNERS LP position in CAPR
CAPRICOR THERAPEUTICS INC COM NEW · Health Care
DIADEMA PARTNERS LP reported holding 329,300 shares of CAPR (CAPRICOR THERAPEUTICS INC COM NEW) in its Q2 2026 13F filing — a position valued at US$7.9M, representing 1.72% of its reported portfolio and ranking #18 among its reported holdings. DIADEMA PARTNERS LP has disclosed CAPR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DIADEMA PARTNERS LP's CAPR position evolved
DIADEMA PARTNERS LP first disclosed a stake in CAPR in Q4 2024 at 58,700 shares (US$810K). The position peaked in Q2 2026 at 329,300 shares, worth US$7.9M. Across 7 filings, DIADEMA PARTNERS LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 329,300 shares valued at US$7.9M — an increase of 250,449 shares quarter over quarter.. Notable position changes include a 252% increase in Q2 2025 (shares fell 27% over the following quarter), a 181% increase in Q3 2025 (shares rose 300% over the following quarter), a 318% increase in Q2 2026 (shares fell 61% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 58.70K | $810.06K | New |
| Q1 2025 | 30.30K | $287.55K | Reduce |
| Q2 2025 | 106.60K | $1.06M | Add |
| Q3 2025 | 300.00K | $2.16M | Add |
| Q4 2025 | 158.07K | $4.56M | Reduce |
| Q1 2026 | 78.85K | $2.40M | Reduce |
| Q2 2026 | 329.30K | $7.93M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAPR and 13F data
CAPR (CAPRICOR THERAPEUTICS INC COM NEW) is a Health Care company. 64 other funds we track also report a position in CAPR — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$98.7M), MONTANOVA CAPITAL, LLC (US$98.6M), RA CAPITAL MANAGEMENT, L.P. (US$36.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAPR
- TANG CAPITAL MANAGEMENT LLC 4.10M sh · $98.73M · Q2 2026
- MONTANOVA CAPITAL, LLC 4.09M sh · $98.55M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.51M sh · $36.31M · Q2 2026
- Boxer Capital Management, LLC 1.40M sh · $33.60M · Q2 2026
- Soleus Capital Management, L.P. 761.74K sh · $18.34M · Q2 2026
- DG Capital Management, LLC 611.60K sh · $14.73M · Q2 2026
- Jones Hill Capital LP 420.75K sh · $10.13M · Q2 2026
- Ikarian Capital, LLC 350.00K sh · $8.43M · Q2 2026
- Palo Alto Investors LP 229.76K sh · $5.53M · Q2 2026
More on DIADEMA PARTNERS LP
FAQ
How long has DIADEMA PARTNERS LP held CAPR?
DIADEMA PARTNERS LP has disclosed CAPR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is DIADEMA PARTNERS LP's current position in CAPR?
As of Q2 2026, DIADEMA PARTNERS LP holds 329.30K shares of CAPR (CAPRICOR THERAPEUTICS INC COM NEW), valued at $7.93M, representing 1.72% of its reported portfolio and ranking #18.
Has DIADEMA PARTNERS LP been buying or selling CAPR?
In the latest 13F filing (Q2 2026), DIADEMA PARTNERS LP increased its position in CAPR. The position peaked in Q2 2026 at 329.30K shares.
Which other funds hold CAPR?
Other major institutional holders of CAPR include TANG CAPITAL MANAGEMENT LLC, MONTANOVA CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.